Research programme: topical wound, inflammation and pain therapies - BioChemics

Drug Profile

Research programme: topical wound, inflammation and pain therapies - BioChemics

Alternative Names: BC-DN-01 topical; Benfotiamine topical - BioChemics

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator BioChemics
  • Class Essential amino acids; Nicotinic-acids; Retinoids; Small molecules; Vitamins
  • Mechanism of Action Antioxidants; Mitochondrial protein stimulants; Nitric oxide donors; Transketolase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Diabetic neuropathies; Inflammation; Skin ulcer; Wounds

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for research development in Skin-ulcer in USA (Topical)
  • 16 Jul 2016 No recent reports of development identified for research development in Wounds in USA (Topical)
  • 16 Jul 2016 No recent reports of development identified for research development in Diabetic-neuropathies in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top